Bleeding Disorders Grants

National Hemophilia Foundation Judith Graham Poole Postdoctoral Research Fellowship

Letter of Intent Deadline: November 23, 2010
Application Deadline: February 23, 2011
Award Start Date: July 1, 2011

The program is named for Dr. Judith Graham Pool. In 1965, Dr. Pool discovered a simple method of extracting the clotting factor from human plasma. This opened the door to a series of rapid developments that revolutionized the treatment of hemophilia including replacement therapy. Replacement therapy (i.e., the infusion of the missing clotting factor to prevent or stop bleeding) has made it possible for people with hemophilia to live relatively normal and productive lives and to avoid, in large measure, the potentially crippling effects of the disorder.

Only noncommercial institutions and investigators associated with a noncommercial institution are eligible for NHF funding.

All grant and fellowship applications are subjected to a rigorous peer review process. Applications are critiqued on scientific merit and relevance to NHF research priorities. Applications are reviewed and scored in terms of significance, approach, innovation, investigator, and environment. A panel selected by the Research Working Group, a volunteer group of scientific and lay leaders, reviews applications received.

Eligibility
Applicants must have completed doctoral training and must enter the JGP fellowship program from a doctoral, postdoctoral, internship or residency training program. Established investigators or faculty members are not eligible. Applicants must be affiliated with domestic organizations such as universities, colleges, hospitals and laboratories. US citizenship is not required.

Permissible research topics include clinical or basic research on the biochemical, genetic, hematologic, orthopedic, psychiatric or dental aspects of the hemophilias or von Willebrand disease. Other topics include rehabilitation, therapeutic modalities, psychosocial issues, women's health issues, liver disease, or AIDS/HIV as they pertain to the hemophilias or von Willebrand disease.

It is expected that the fellow will spend at least 90% of the time on the research project for which funding is requested. The remaining 10% may be devoted to teaching or clinical work that is relevant to the research.

Funding
Support is available for up to $42,000/per year for a maximum of two years (pending continuing grant approval).

Letter of Intent
All interested candidates must submit a letter of intent by 5pm EST, November 23, 2010. This should be a brief letter identifying the researcher, their mentor, institution and a description of the proposed research project. Letters of intent should include an NIH-style CV or biosketch for both candidate and mentor. Letters of intent will be evaluated by members of NHF's Research Review Committee who will collectively decide upon the candidates invited to submit a full JGP application.

Inquiries
For further information, contact:

Angelina Wang
Director of Research and Medical Information
116 West 32nd Street, 11th floor
New York, NY 10001
Phone: (212) 328-3727 or (800) 42-HANDI ext. 3727
Fax: (212) 328-3799
E-mail: awang@hemophilia.org

American Society of Hematology Alternative Training Pathway Grant

The Alternative Training Pathway Grant is intended to foster the development and/or implementation of creative new curricula for trainees in clinical and clinical/translational hematology and related fields. A growing number of trainees are expressing an interest in pursuing hybrid careers (e.g., medicine/pediatrics) and/or a desire to become trained in both clinical care and laboratory medicine (e.g., transfusion medicine or directing hemostasis laboratories). There is a perceived need for specialists with integrated expertise in hematology and other rapidly evolving areas of applied medicine such as vascular biology, stem cell technologies, cellular therapeutics, and targeted pharmacotherapeutics, laboratory oversight, and transfusion medicine. The Alternative Training Pathway Grant is designed to allow training program directors the opportunity to develop curricula that meets these new demands. Examples of previously funded initiatives include integrated pathways in adult and pediatric benign hematology; pediatric hemostasis-thrombosis and pharmacology; and hematology and palliative care.

Support

Grants of up to $50,000 will be awarded to support the development and implementation of novel hematology-related training programs as an alternative to traditional training programs. The award may be expended over a one- to two-year period of time. No institutional overhead (i.e., indirect) costs will be supported by this grant.
Eligibility

Applicants must be Training Program Directors and other educators, and Active Members of the American Society of Hematology (ASH) at institutions with an accredited training program(s) in adult or pediatric hematology or hematology/medical oncology, or in other hematology-related disciplines (e.g., pathology specialties) in the United States, Canada, or Mexico. Awards are limited to only one application per institution. Awardees must commit to providing progress reports and final reports as defined in the terms of the grant.

Proposed Curriculum

The proposed curriculum should be able to integrate within an accredited hematology, hematology/oncology, and/or hematology-related specialty training program. Inter-disciplinary initiatives are encouraged, and multi-institutional programs will be considered.

Applicants should:

* Describe the proposed new or alternative training pathway(s).
* Discuss how career development and the scope of career opportunities will be enhanced through the proposed training pathway(s).
* If an inter-disciplinary initiative is proposed, describe how cross-training and certification in fields related to hematology may be pursued or how defined specialty barriers might be breached (e.g., medicine and pediatrics).
* Describe how the curriculum could be disseminated to other training programs if applicable.
* Describe plans to achieve sustainability of the pathway over time.

Examples of innovative pathways include: 1) Hematology and Laboratory Oversight Pathways (e.g. Special Coagulation Laboratory); 2) Hematology and Transfusion Medicine with an emphasis on apharesis.

Letter of Intent

Letters of Intent for the 2011 application cycle will be due via e-mail no later than 5:00 p.m. EST, on Tuesday, February 2, 2011. Those who have fulfilled the Letter of Intent requirements will be invited to apply.

Questions regarding this application and the ASH Alternative Training Pathway Grant should be directed to Joe Basso, Training Manager, at jbasso@hematology.org or 202-552-4910.

National Hemophilia Foundation Physical Therapy Excellence Fellowship

Letter of intent submission deadline February 1, 2011

All grant and fellowship applications are subjected to a rigorous peer review process. Applications are critiqued on scientific merit and relevance to NHF research priorities. Applications are reviewed and scored in terms of significance, approach, innovation, investigator, and environment. A volunteer group of scientific and lay leaders reviews applications received. The NHF Medical and Scientific Advisory Council (MASAC) and the NHF Board of Directors grant final funding approval.

Eligibility
The objectives of the Physical Therapy Fellowship are to improve the delivery of physical therapy care and expand the knowledge base specific to hemophilia.

It is expected that the fellowship will provide support for a physical therapist currently employed or interested in hemophilia care to conduct physical therapy research or clinical projects related to the care of the patient with hemophilia.

Current topics of interest may include but are not limited to the following: development of clinical pathways, physical therapy protocols, physical therapy utilization, measurable outcome studies, rehabilitation programs, use of modalities and other intervention commonly used by physical therapists in the treatment of the patient with hemophilia.

Funding
NHF awards one new research fellowship per year of $10,000. Awards are made for one calendar year.

Deadlines

A letter of intent should be submitted to NHF. This should be a brief letter identifying the applying researcher and organization and the intended area of research.

Multidisciplinary applications are welcomed. If a multidisciplinary project is sought, you are encouraged to indicate in the letter of intent and in the application how the project would proceed if only one Fellowship is awarded.

Inquiries
For inquiries regarding applications, policy and procedures and programmatic information, contact:

Morgan Johnson, CAE, Manager of Healthcare Provider Programs
National Hemophilia Foundation
116 West 32nd Street, 11th Floor
New York, NY 10001
(800) 424-2634 ext. 3745 or (212) 328-3745
Fax: (212) 328-3799
E-mail: mjohnson@hemophilia.org

Direct inquiries regarding fiscal matters to:

Department of Finance and Administration
National Hemophilia Foundation
116 West 32nd Street, 11th Floor
New York, NY 10001
(800) 424-2634 ext. 3726 or (212) 328-3726
Fax 212-328-3766

National Hemophilia Foundation Social Work Excellence Fellowships

Letter of intent submission deadline February 1, 2011

All grant and fellowship applications are subjected to a rigorous peer review process. Applications are critiqued on scientific merit and relevance to NHF research priorities. Applications are reviewed and scored in terms of significance, approach, innovation, investigator, and environment. A panel selected by the Research Working Group, a volunteer group of scientific and lay leaders, reviews applications received. The NHF Medical and Scientific Advisory Council (MASAC) and the NHF Board of Directors grant final funding approval.

Eligibility
To be eligible for the fellowship the applicant must: be an MSW from an accredited school of social work or be a student in a DSW program or have a master's degree in a social work related field, be licensed by the state to practice as a master's level clinical social worker and work in a bleeding disorders program. Professional experience in a hemophilia treatment center is desirable but not required. The proposed project, however, must have relevance to current practice in bleeding disorders care and may incorporate casework, group work, organizational and public health, education and research perspectives.

It is expected that the project will: (1) promote the integration of psychosocial care with biomedical components of comprehensive care; (2) promote the delivery of quality services to patients and families; (3) contribute to the literature on the psychosocial aspects of bleeding disorders; (4) demonstrate social work outcomes of the research or clinical project.

Areas of research interest might include some of the following topics: impact of social work practice on coping with chronic illness and/or disability; impact of case management on patient care; improved clinical practice; research skills and goals for psychosocial providers; mental health issues of those affected with bleeding disorders or bleeding disorders/HIV; development and use of media projects and/or learning tools for professional or patient evaluation. A focus on cultural diversity is welcomed.

Funding
NHF awards one new research fellowship per year of $10,000.

Deadlines

A letter of intent should be submitted to NHF. This should be a brief letter identifying the applying researcher and organization and the intended area of research.

Multidisciplinary applications are welcomed. If a multidisciplinary project is sought, you are encouraged to indicate in the letter of intent and in the application how the project would proceed if only one Fellowship is awarded.

Inquiries
For inquiries regarding applications, policy and procedures and programmatic information, contact:

Morgan Johnson, CAE, Manager of Healthcare Provider Programs
National Hemophilia Foundation
116 West 32nd Street, 11th Floor
New York, NY 10001
(800) 424-2634 ext. 3745 or (212) 328-3745
Fax: (212) 328-3799
E-mail: mjohnson@hemophilia.org

Direct inquiries regarding fiscal matters to:

Department of Finance and Administration
National Hemophilia Foundation
116 West 32nd Street, 11th Floor
New York, NY 10001
(800) 424-2634 ext. 3726 or (212) 328-3726
Fax 212-328-3766

Hemophilia Foundation Nursing Excellence Fellowships

Letter of intent submission deadline February 1, 2011

All grant and fellowship applications are subjected to a rigorous peer review process. Applications are critiqued on scientific merit and relevance to NHF research priorities. Applications are reviewed and scored in terms of significance, approach, innovation, investigator, and environment. A volunteer group of scientific and lay leaders reviews applications received. The NHF Medical and Scientific Advisory Council (MASAC) and the NHF Board of Directors grant final funding approval.

Eligibility
The purpose of the National Hemophilia Foundation Nursing Fellowship is to provide support for a registered nurse currently employed or interested in hemophilia care to conduct nursing research or clinical projects. Endorsement by a federally funded hemophilia treatment center is recommended. Only registered nurses from an accredited nursing school enrolled in a graduate nursing program or practicing hemophilia nursing care may apply.

Collaboration with multidisciplinary care providers and/or between 2 or more hemophilia centers is accepted and encouraged. Collaboration efforts may include, for example, social work, physical therapy and genetics. It thus may be possible for a hemophilia center team to apply jointly for two or more of the nursing, social work and physical therapy excellence fellowships as a cooperative project or research endeavor. Additionally, regional applications will be considered.

Current topics of interest include, but are not limited to, the development of clinical pathways, measurable outcomes in bleeding disorders care, service utilization, epidemiology and patient and community education tools. Other topics include rehabilitation, therapeutic modalities, psychosocial issues, women's health in bleeding disorders, liver disease in clients with bleeding disorders and HIV/AIDS. The objectives of the fellowship are to improve the delivery of care and expand the knowledge of nursing science surrounding bleeding disorders.

Funding
Each year one new research fellowship of up to $13,500 will be awarded.

Deadlines

A letter of intent should be submitted to NHF. This should be a brief letter identifying the applying researcher and organization and the intended area of research.

Multidisciplinary applications are welcomed. If a multidisciplinary project is sought, you are encouraged to indicate in the letter of intent and in the application how the project would proceed if only one Fellowship is awarded.

Inquiries
For inquiries regarding applications, policy and procedures and programmatic information, contact:

Morgan Johnson, CAE, Manager of Healthcare Provider Programs
National Hemophilia Foundation
116 West 32nd Street, 11th Floor
New York, NY 10001
(800) 424-2634 ext. 3745 or (212) 328-3745
Fax: (212) 328-3799
E-mail: mjohnson@hemophilia.org

Direct inquiries regarding fiscal matters to:

Department of Finance and Administration
National Hemophilia Foundation
116 West 32nd Street, 11th Floor
New York, NY 10001
(800) 424-2634 ext. 3726 or (212) 328-3726
Fax 212-328-3766

National Hemophilia Foundation-Baxter Clinical Fellowship Program

Institutional Application Deadline: December 1, 2010
Candidate Application: December 1, 2010
Award Start Date: July 1, 2011

The National Hemophilia Foundation-Baxter Clinical Fellowship Program, funded through the generous support of Baxter Healthcare Corporation, is intended to increase the number of skilled clinicians committed to providing comprehensive care for individuals with bleeding and clotting disorders. The program is designed to provide hands-on clinical training to licensed physicians not to mention prepare them for academic careers in bleeding and clotting disorders research. Mentored training takes place at highly-qualified hemophilia and thrombophilia treatment centers located throughout the United States. Funding is provided to cover costs associated with training promising physicians who show interest in devoting their careers to the care of patients with hemophilia and other bleeding or clotting disorders.

In the field of rare disorders, hemophilia has long been touted as a model for medical care delivery since the majority of patients benefit from treatment in comprehensive care centers. However, this highly specialized care system has become increasingly fragile as a generation of HTC physicians either retire or choose to leave the field. Such departures are accelerating as an ironic byproduct of the HTC success story: More and more patients receive prophylaxis and preventative care; more individuals are able to infuse themselves at home, resulting in a reduction of patient-doctor contact hours. This situation, coupled with a relatively stable to low number of hemophilia patients, has imperiled the profession as a viable full-time practice. Other more systemic problems have included the lack of comprehensive training programs for bleeding disorder specialists and reduced institutional support for hemophilia clinical care and research. Amidst these concerns, there also exists an inadequate system for meeting the needs of individuals affected by thrombosis and inherited thrombophilias. One proposed solution for meeting these patients’ needs is to support the training of physicians who are skilled in the treatment of both conditions at specially-designated care centers. NHF and Baxter firmly believe that this solution offers the means to further increase the number of quality treatment centers, the number of providers attracted to this field and also spur institutional support.

How to Apply
Individual nominations for the NHF-Baxter Clinical Fellowship can only be made by institutions that have already applied and received approval to participate in the program. Therefore, applying to the NHF-Baxter Clinical Fellowship Program is a two-tiered process.

Step One: Institutional Application – This application is intended for the medical director(s) and other senior faculty members/administrators affiliated with U.S. hemophilia and thrombophilia treatment centers not yet approved to participate in the NHF-Baxter Clinical Fellowship Program. Only authorized institutions may subsequently nominate and train NHF-Baxter Clinical Fellows. If approved, authorization is granted for a period of five years. Approved institutions must submit a re-application every five years, subject to review and approval, in order to continue their participation in the NHF-Baxter Clinical Fellows Program.

Step Two: Candidate Application – This application is intended for the medical director(s) and other senior faculty members/administrators from approved U.S. hemophilia and thrombophilia treatment centers to nominate qualified candidates as NHF-Baxter Clinical Fellows. From among these candidates, two NHF-Baxter Clinical Fellows are selected each year and awarded up to $100,000 per year, for up to two years.

For further information, please contact:

Angelina Wang
Director, Research and Medical Information
116 West 32nd Street, 11th floor
New York, NY 10001
Phone: (212) 328-3727 or (800) 42-HANDI
Fax: (212) 328-3799
E-mail: awang@hemophilia.org